This is the second major acquisition for Prime Global since it partnered with Levine Leichtman Capital Partners in April 2021.
Partnering with pharma companies has been a key aspect of Arpeggio’s early success, according to CEO Joey Azofeifa.
This marks a major initiative for Imunon CEO Dr. Corinne Le Goff, who joined the company after serving as chief commercial officer at Moderna.
The move expands the Danish pharma company’s sickle cell disease portfolio.
Jeremiah Hanes, Ph.D., joins Ansa after more than a dozen years at PacBio.
The vaccine and Vifor units will now begin with the CSL initials, while the pharma and plasma units maintain their identity.
The company wants to emphasize its mission to deliver on the promise of mRNA science.
Vertex’s $320 million cash acquisition of ViaCyte is anticipated to close by the end of the year.
Bluebird’s wins were followed by news over the weekend that patients with inherited blood disease saw prolonged benefit from gene-edited therapy.
Briefing documents suggest that one of two potential gene therapy launches may be in for a rough ride.
MM+M is proud to announce the fourth annual Pinnacle Awards program, which celebrates the medical marketing industry’s most venerable marketers, strategists and creators.
Get the most out of
Register for free and enjoy unlimited access to: